2026 Educational Objectives

Upon completion of the program, the participant should be able to:

Compare benefits vs risks of dual continuous glucose & ketone monitoring;
Identify appropriate use of GLP-1 analogs for individualized diabetes & obesity management;
Evaluate different AID systems for use in T1D & T2D care;
Identify common comorbidities & complications in patients with diabetes;
Assess appropriate strategies for glucose management in special populations.

Upon completion of this program, the participant should be able to:

Participants will engage with cutting-edge advancements transforming diabetes care — from dual glucose and ketone monitoring and next-generation AID systems to breakthroughs in gene editing, cardiometabolic health, and early intervention in Type 1 diabetes.

The conference empowers attendees to integrate innovation with clinical practice, driving personalized, data-informed, and technology-enabled solutions to optimize outcomes across the spectrum of diabetes management.